J.P. Morgan Private Wealth Advisors LLC - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 60 filers reported holding UROGEN PHARMA LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
J.P. Morgan Private Wealth Advisors LLC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q1 2019$537,000
-12.5%
14,543
+2.1%
0.00%
-25.0%
Q4 2018$614,000
-19.9%
14,250
-12.3%
0.00%0.0%
Q3 2018$767,000
+25.7%
16,250
+32.7%
0.00%
+33.3%
Q2 2018$610,000
+0.2%
12,2500.0%0.00%
-25.0%
Q1 2018$609,000
+33.6%
12,2500.0%0.00%
+33.3%
Q4 2017$456,000
+18.1%
12,2500.0%0.00%0.0%
Q3 2017$386,000
+74.7%
12,2500.0%0.00%
+50.0%
Q2 2017$221,00012,2500.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q2 2018
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 900,148$23,512,0008.12%
Horton Capital Management, LLC 383,428$10,015,0007.55%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$77,177,0001.89%
Phoenix Holdings Ltd. 897,464$22,251,0000.94%
SHIKIAR ASSET MANAGEMENT INC 51,175$1,337,0000.61%
Migdal Insurance & Financial Holdings Ltd. 738,302$19,284,0000.31%
Coastal Bridge Advisors, LLC 37,000$966,0000.31%
Clal Insurance Enterprises Holdings Ltd 529,388$13,828,0000.27%
ALGERT GLOBAL LLC 10,880$284,0000.10%
BANK HAPOALIM BM 14,831$387,0000.09%
View complete list of UROGEN PHARMA LTD shareholders